Inflammation and Residual Risk: What will be learned from CANTOS and CIRT

Learning Objectives

• Understand the concept of residual inflammatory risk
• Review some of the core basic and translational concepts of inflammation and atherothrombosis
• Understand the rationale and design of the ongoing inflammatory reduction trials

Faculty

Paul M Ridker
MD, MPH
Eugene Braunwald Professor of Medicine, Harvard Medical School
Director, Center of Cardiovascular Disease Prevention, Brigham and Women’s

Subodh Verma
MD, PhD, FRCSC, FAHA
Division of Cardiac Surgery, St. Michael’s Hospital
Professor Surgery and Pharmacology & Toxicology, University of Toronto